EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2272 participants.

Also called NCT01069003

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,272 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01069003
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01069003. Randomized; triple masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2016-01-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
Acronym
EDUCATE
Intervention (Drug)
Placebo Arm
Intervention (Drug)
Thienopyridine Therapy
Intervention (Device)
Surveillance Arm
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct01069003
Content hash
46c66d7ccdbed1bbf34a6c87cfd965f5df37e8591bd2144c29b02a96fce49f8f